BWL
BEAM icon

Bogart Wealth LLC’s Beam Therapeutics BEAM Stock Holding History

Bogart Wealth LLC’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262 Hold
11
– – ﹤0.01% 1681
2025
Q4 		$305 Hold
11
– – ﹤0.01% 1523
2025
Q3 		$267 Hold
11
– – ﹤0.01% 1476
2025
Q2 		$187 Hold
11
– – ﹤0.01% 1411
2025
Q1 		$215 Hold
11
– – ﹤0.01% 1348
2024
Q4 		$273 Hold
11
– – ﹤0.01% 1301
2024
Q3 		$270 Hold
11
– – ﹤0.01% 1091
2024
Q2 		$258 Hold
11
– – ﹤0.01% 1080
2024
Q1 		$363 Hold
11
– – ﹤0.01% 1024
2023
Q4 		$299 Hold
11
– – ﹤0.01% 1020
2023
Q3 		$265 Hold
11
– – ﹤0.01% 1034
2023
Q2 		$351 Hold
11
– – ﹤0.01% 1003
2023
Q1 		$337 Sell
11
-23
-68% -$908 ﹤0.01% 1056
2022
Q4 		$1.33K Sell
34
-15
-31% -$672 ﹤0.01% 835
2022
Q3 		$2K Buy
49
+15
+44% +$856 ﹤0.01% 810
2022
Q2 		$1K Hold
34
– – ﹤0.01% 812
2022
Q1 		$2K Hold
34
– – ﹤0.01% 661
2021
Q4 		$3K Buy
34
+11
+48% +$942 ﹤0.01% 606
2021
Q3 		$2K Buy
+23
New +$2.31K ﹤0.01% 622

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Bogart Wealth LLC's BEAM Position: Q1 2026 in Review

Bogart Wealth LLC held its Beam Therapeutics (BEAM) position steady in Q1 2026 at 11 shares worth $262. The position accounts for ﹤0.01% of the portfolio, ranked #1681.

Bogart Wealth LLC first reported a position in BEAM in Q3 2021 and has held it in 19 quarters since. The position peaked at $3K in Q4 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Bogart Wealth LLC held 11 shares of Beam Therapeutics worth $262 as of Q1 2026.
  • Bogart Wealth LLC left its Beam Therapeutics share count unchanged in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q1 2026, its #1681 holding.
  • Bogart Wealth LLC first reported a position in Beam Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Bogart Wealth LLC's Beam Therapeutics position peaked at $3K in Q4 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.